News Conference News TCT 2022 TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US Caitlin E. Cox September 16, 2022
News Daily News Early LV Recovery After TAVI Points to Better 5-Year Survival Yael L. Maxwell August 01, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Conference News TVT 2022 Surgical Explant or Redo for TAVI Failures? Some Registry Insights Michael O'Riordan June 10, 2022
Presentation TVT 2022 Key features for a first valve in a low-risk patient Presenter: Katherine Harrington June 09, 2022
News Conference News EuroPCR 2022 Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients Yael L. Maxwell May 27, 2022
News Conference News EuroPCR 2022 Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO Yael L. Maxwell May 23, 2022
News Daily News ‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible Michael O'Riordan March 21, 2022
News Daily News Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients Todd Neale March 16, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Conference News Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients Todd Neale March 01, 2022
News Conference News STS 2022 Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database L.A. McKeown February 02, 2022
News Daily News ‘Home Time’ Validated as TAVI Outcomes Performance Metric L.A. McKeown January 11, 2022
News Daily News SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS L.A. McKeown November 30, 2021
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Daily News US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access L.A. McKeown November 23, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021